Stock Taper
OPPORTUNITY RADAR
SCREENER
COMPARE ANY 2 STOCKS
Pricing
Log In
SIGN UP
EARNINGS CALL ARCHIVE
4 CALLS ON FILE
NRXP
— NRx Pharmaceuticals, Inc.
NASDAQ
FULL STOCK PAGE →
Q4 2025 Earnings Call Summary
MAR 24, 2026
REVENUE
$983000
+306.2%
NET MARGIN
36.6%
+2470.5 PTS
EPS
$0.01
+104.2%
FREE CASH FLOW
-$3.7M
-28.4%
No summary has been written for this call yet.
← NEWER CALL
CALL 3 OF 4
OLDER CALL →